{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:44:19Z","timestamp":1772808259574,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CeloNova"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.carrev.2019.11.005","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T20:41:56Z","timestamp":1573245716000},"page":"195-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Time Course of Reendothelialization with Polyzene-F Nanocoated Cobra PzF\u2122 Coronary Stent on Rabbit Iliac Arteries"],"prefix":"10.1016","volume":"21","author":[{"given":"Luc","family":"Maillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Corseaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Alti\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Ung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00ebl","family":"Courageot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Teiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Van Belle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.carrev.2019.11.005_bb0005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease","volume":"331","author":"Serruys","year":"1994","journal-title":"Benestent Study Group N Engl J Med"},{"issue":"17","key":"10.1016\/j.carrev.2019.11.005_bb0010","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Schomig","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.11.005_bb0015","doi-asserted-by":"crossref","unstructured":"Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol. 2007;50(14):1299\u2013304. doi:S0735\u20131097(07)02206\u20131 [pii] https:\/\/doi.org\/10.1016\/j.jacc.2007.06.029.","DOI":"10.1016\/j.jacc.2007.06.029"},{"key":"10.1016\/j.carrev.2019.11.005_bb0020","doi-asserted-by":"crossref","unstructured":"Camenzind E, Wijns W, Mauri L, Kurowski V, Parikh K, Gao R et al. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet. 2012;380(9851):1396\u2013405. doi:S0140\u20136736(12)61336\u20131 [pii] https:\/\/doi.org\/10.1016\/S0140-6736(12)61336-1.","DOI":"10.1016\/S0140-6736(12)61336-1"},{"key":"10.1016\/j.carrev.2019.11.005_bb0025","first-page":"347","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis","volume":"f6530","author":"Navarese","year":"2013","journal-title":"BMJ."},{"issue":"5","key":"10.1016\/j.carrev.2019.11.005_bb0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ahj.2009.02.007","article-title":"Incidence of stent thrombosis and adverse cardiac events 5 years after sirolimus stent implantation in clinical practice","volume":"157","author":"Goy","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2019.11.005_bb0035","doi-asserted-by":"crossref","unstructured":"Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45(6):947\u201353. doi:S0735-1097(05)00148-8 [pii] https:\/\/doi.org\/10.1016\/j.jacc.2004.09.079.","DOI":"10.1016\/j.jacc.2004.09.079"},{"issue":"11","key":"10.1016\/j.carrev.2019.11.005_bb0040","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry","volume":"10","author":"Capodanno","year":"2015","journal-title":"EuroIntervention."},{"key":"10.1016\/j.carrev.2019.11.005_bb0045","doi-asserted-by":"crossref","unstructured":"Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501\u201355. doi:ehq277 [pii] https:\/\/doi.org\/10.1093\/eurheartj\/ehq277.","DOI":"10.1093\/eurheartj\/ehq277"},{"key":"10.1016\/j.carrev.2019.11.005_bb0050","doi-asserted-by":"crossref","unstructured":"Urban P, Abizaid A, Banning A, Bartorelli AL, Baux AC, Dzavik V et al. Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. J Am Coll Cardiol. 2011;57(13):1445\u201354. doi:S0735\u20131097(11)00187\u20132 [pii] https:\/\/doi.org\/10.1016\/j.jacc.2010.11.028.","DOI":"10.1016\/j.jacc.2010.11.028"},{"key":"10.1016\/j.carrev.2019.11.005_bb0055","doi-asserted-by":"crossref","unstructured":"Kwok CS, Bulluck H, Ryding AD, Loke YK. Benefits and harms of extending the duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stents: a meta-analysis. ScientificWorldJournal. 2014;2014:794078. doi:https:\/\/doi.org\/10.1155\/2014\/794078","DOI":"10.1155\/2014\/794078"},{"issue":"1","key":"10.1016\/j.carrev.2019.11.005_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-9560-10-22","article-title":"Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis","volume":"10","author":"Menozzi","year":"2012","journal-title":"Thromb J"},{"issue":"2","key":"10.1016\/j.carrev.2019.11.005_bb0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/jcis.1997.5238","article-title":"Plasma protein adsorption and platelet adhesion on poly","volume":"197","author":"Welle","year":"1998","journal-title":"J Colloid Interface Sci"},{"issue":"2","key":"10.1016\/j.carrev.2019.11.005_bb0070","first-page":"89","article-title":"Haemocompatibility of polymer-coated stainless steel stents as compared to uncoated stents","volume":"32","author":"Mrowietz","year":"2005","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.carrev.2019.11.005_bb0075","doi-asserted-by":"crossref","unstructured":"Richter GM, Stampfl U, Stampfl S, Rehnitz C, Holler S, Schnabel P et al. A new polymer concept for coating of vascular stents using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to reduce thrombogenicity and late in-stent stenosis. Invest Radiol. 2005;40(4):210\u20138. doi:00004424\u2013200504000-00004 [pii].","DOI":"10.1097\/01.rli.0000156195.74967.47"},{"issue":"5","key":"10.1016\/j.carrev.2019.11.005_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.rli.0000261439.90760.9d","article-title":"The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model","volume":"42","author":"Satzl","year":"2007","journal-title":"Invest Radiol"},{"issue":"5","key":"10.1016\/j.carrev.2019.11.005_bb0085","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00270-007-9243-y","article-title":"Restenosis of the CYPHER-Select, TAXUS-express, and Polyzene-F nanocoated cobalt-chromium stents in the minipig coronary artery model","volume":"31","author":"Radeleff","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.carrev.2019.11.005_bb0090","doi-asserted-by":"crossref","unstructured":"Jinnouchi H, Mori H, Cheng Q, Kutyna M, Torii S, Sakamoto A et al. Thromboresistance and Functional Healing in the COBRA PzF Stent versus Competitor DES: implications for Dual Anti-Platelet Therapy. EuroIntervention. 2018. doi:EIJ-D-18-00740 [pii] https:\/\/doi.org\/10.4244\/EIJ-D-18-00740.","DOI":"10.4244\/EIJ-D-18-00740"},{"issue":"2","key":"10.1016\/j.carrev.2019.11.005_bb0095","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heart.89.2.133","article-title":"Drug eluting stents: are human and animal studies comparable?","volume":"89","author":"Virmani","year":"2003","journal-title":"Heart."},{"issue":"2","key":"10.1016\/j.carrev.2019.11.005_bb0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/01.CIR.95.2.438","article-title":"Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition","volume":"95","author":"Van Belle","year":"1997","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.carrev.2019.11.005_bb0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1161\/01.CIR.75.2.452","article-title":"Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method","volume":"75","author":"Mancini","year":"1987","journal-title":"Circulation."},{"issue":"10","key":"10.1016\/j.carrev.2019.11.005_bb0110","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa066633","article-title":"A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Spaulding","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2019.11.005_bb0115","doi-asserted-by":"crossref","unstructured":"Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007;356(10):1030\u20139. doi:NEJMoa067484 [pii] https:\/\/doi.org\/10.1056\/NEJMoa067484.","DOI":"10.1056\/NEJMoa067484"},{"key":"10.1016\/j.carrev.2019.11.005_bb0120","doi-asserted-by":"crossref","unstructured":"Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356(10):998\u20131008. doi:NEJMoa067193 [pii] https:\/\/doi.org\/10.1056\/NEJMoa067193.","DOI":"10.1056\/NEJMoa067193"},{"key":"10.1016\/j.carrev.2019.11.005_bb0125","doi-asserted-by":"crossref","unstructured":"Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol. 2006;98(3):352\u20136. doi:S0002\u20139149(06)00720-X [pii] https:\/\/doi.org\/10.1016\/j.amjcard.2006.02.039.","DOI":"10.1016\/j.amjcard.2006.02.039"},{"key":"10.1016\/j.carrev.2019.11.005_bb0130","doi-asserted-by":"crossref","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126\u201330. doi:293\/17\/2126 [pii] https:\/\/doi.org\/10.1001\/jama.293.17.2126.","DOI":"10.1001\/jama.293.17.2126"},{"issue":"6","key":"10.1016\/j.carrev.2019.11.005_bb0135","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation."},{"issue":"23","key":"10.1016\/j.carrev.2019.11.005_bb0140","first-page":"1665","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting","volume":"339","author":"Leon","year":"1998","journal-title":"Stent Anticoagulation Restenosis Study Investigators N Engl J Med"},{"key":"10.1016\/j.carrev.2019.11.005_bb0145","doi-asserted-by":"crossref","unstructured":"Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007;27(7):1500\u201310. doi:ATVBAHA.107.144220 [pii] https:\/\/doi.org\/10.1161\/ATVBAHA.107.144220.","DOI":"10.1161\/ATVBAHA.107.144220"},{"key":"10.1016\/j.carrev.2019.11.005_bb0150","doi-asserted-by":"crossref","unstructured":"Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008;52(5):333\u201342. doi:S0735\u20131097(08)01703\u20138 [pii] https:\/\/doi.org\/10.1016\/j.jacc.2008.04.030.","DOI":"10.1016\/j.jacc.2008.04.030"},{"key":"10.1016\/j.carrev.2019.11.005_bb0155","doi-asserted-by":"crossref","unstructured":"Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008;118(11):1138\u201345. doi:CIRCULATIONAHA.107.762047 [pii] https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.762047.","DOI":"10.1161\/CIRCULATIONAHA.107.762047"},{"key":"10.1016\/j.carrev.2019.11.005_bb0160","doi-asserted-by":"crossref","unstructured":"Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW et al. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. J Am Coll Cardiol. 2011;58(15):1569\u201377. doi:S0735-1097(11)02840-3 [pii] https:\/\/doi.org\/10.1016\/j.jacc.2011.06.049.","DOI":"10.1016\/j.jacc.2011.06.049"},{"key":"10.1016\/j.carrev.2019.11.005_bb0165","doi-asserted-by":"crossref","unstructured":"Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012;125(23):2873\u201391. doi:CIRCULATIONAHA.112.097014 [pii] https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.097014.","DOI":"10.1161\/CIRCULATIONAHA.112.097014"},{"issue":"21","key":"10.1016\/j.carrev.2019.11.005_bb0170","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.carrev.2019.11.005_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.RES.57.1.105","article-title":"Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model","volume":"57","author":"Steele","year":"1985","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2019.11.005_bb0180","doi-asserted-by":"crossref","unstructured":"Van Belle E, Tio FO, Chen D, Maillard L, Kearney M, Isner JM. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J Am Coll Cardiol. 1997;29(6):1371\u20139. doi:S0735109797000491 [pii].","DOI":"10.1016\/S0735-1097(97)00049-1"},{"key":"10.1016\/j.carrev.2019.11.005_bb0185","doi-asserted-by":"crossref","unstructured":"Jimenez JM, Prasad V, Yu MD, Kampmeyer CP, Kaakour AH, Wang PJ et al. Macro- and microscale variables regulate stent haemodynamics, fibrin deposition and thrombomodulin expression. J R Soc Interface. 2014;11(94):20131079. doi:rsif.2013.1079 [pii] https:\/\/doi.org\/10.1098\/rsif.2013.1079.","DOI":"10.1098\/rsif.2013.1079"},{"issue":"8","key":"10.1016\/j.carrev.2019.11.005_bb0190","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s10439-009-9719-9","article-title":"Hemodynamically driven stent strut design","volume":"37","author":"Jimenez","year":"2009","journal-title":"Ann Biomed Eng"},{"issue":"1","key":"10.1016\/j.carrev.2019.11.005_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ncpcardio1397","article-title":"Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology","volume":"6","author":"Davies","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.carrev.2019.11.005_bb0200","first-page":"644","article-title":"Scanning electron microscopic assessment of coating irregularities and their precursors in unexpanded durable polymer-based drug-eluting stents","volume":"79","author":"Basalus","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.11.005_bb0205","doi-asserted-by":"crossref","unstructured":"Guerin P, Pilet P, Finet G, Goueffic Y, N'Guyen JM, Crochet D et al. Drug-eluting stents in bifurcations: bench study of strut deformation and coating lesions. Circ Cardiovasc Interv. 2010;3(2):120\u20136. doi:CIRCINTERVENTIONS.108.846089 [pii] https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.108.846089.","DOI":"10.1161\/CIRCINTERVENTIONS.108.846089"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919307481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919307481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:17:16Z","timestamp":1761560236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919307481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1553838919307481"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.11.005","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time Course of Reendothelialization with Polyzene-F Nanocoated Cobra PzF\u2122 Coronary Stent on Rabbit Iliac Arteries","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}